Transcatheter Valve Therapies (TVT): Featuring Clinical Workshops

Satellite Programs

Thursday, June 15, 2017

Breakfast Programs

6:30 am-7:00 am – Check-in & Breakfast
7:00 am-8:00 am – Program
Breakfast will be served.


The Role of Cerebral Protection in Contemporary TAVR (Non-CME)

Sponsored by Claret Medical, Inc.
Room: Chicago Ballroom X

Chairs

Samir R. Kapadia, MD
Cleveland Clinic
Cleveland, OH

Raj Makkar, MD
Cedars-Sinai Medical Center
Los Angeles, CA

Faculty

Susheel Kodali, MD
NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Martin B. Leon, MD
NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Axel Linke, MD
University of Leipzig, Heart Center
Leipzig, Germany

Renu Virmani, MD
CVPath Institute, Inc.
Gaithersburg, MD

Nicolas M. Van Mieghem, PhD
Erasmus Medical Center
Rotterdam, The Netherlands

Jochen Wörhle, MD
University Hospital Ulm
Ulm, Germany

Agenda

7:00 am Introduction: Neurological Insults During TAVR and SAVR – Their Clinical Consequence and Relevance
Samir R. Kapadia
7:05 am The Weight of Clinical Evidence Supporting the Need For Cerebral Protection for All Contemporary Valves
Axel Linke
7:15 am Real-world Data Demonstrating Reduction in Clinical Stroke and Mortality in TAVR With Sentinel®
Jochen Wörhle
7:25 am Cerebral Embolic Debris Is Ubiquitous in TAVR Irrespective of Risk Score
Nicolas M. Van Mieghem
7:35 am The Role of Cerebral Protection in the Era of Shared Decision-making
Martin B. Leon
7:45 am Conclusion: How the Use of Cerebral Protection Will Strengthen Your TAVR Practice
Raj Makkar
7:50 am Panel Q&A
Faculty & Panel
8:00 am Adjourn

Why Transcatheter Mitral Annuloplasty Should Be the First Tool in Your Mitral Repair Toolbox (Non-CME)

Sponsored by Cardiac Dimensions
Room: Chicago Ballroom VIII

Chairs

Martin B. Leon, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

R. Stephan von Bardeleben, MD
University Medical Center Mainz
Mainz, Germany

Faculty

Steven L. Goldberg, MD
Community Hospital of the Monterey Peninsula
Monterey, CA

Samir R. Kapadia, MD
Cleveland Clinic
Cleveland, OH

Klaus K. Witte, MD
University of Leeds and Leeds Teaching Hospitals
Leeds, United Kingdom

Agenda

7:00 am   Introduction
Martin B. Leon
7:10 am   An Overview of Device Therapies for Functional MR in the Setting of Heart Failure
Klaus K. Witte
7:25 am   Opening New Therapeutic Avenues: The Use of Adjunctive Percutaneous Mitral Repair Therapies
R. Stephan Von Bardeleben
7:40 am   The Importance of Randomized, Blinded Trials for Mitral Repair Therapies: A Review of The CARILLON Trial
Samir R. Kapadia
7:55 am   Questions
8:00 am   Adjourn

Lunch Programs

12:15 pm-12:30 pm – Check-in & Lunch
12:30 pm-1:30 pm – Program
Lunch will be served.


The TAVR Revolution: The Treatment of Aortic Stenosis Has Changed (CME)

Sponsored by the Cardiovascular Research Foundation
Supported through an educational grant from Edwards Lifesciences

Room: Chicago Ballroom X

Chairs

Martin B. Leon, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Vinod H. Thourani, MD
Emory University Healthcare
Atlanta, GA

Faculty

Philippe Généreux, MD
Gagnon Cardiovascular Institute/Morristown Medical Center
Morristown, NJ

Susheel Kodali, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

James M. McCabe, MD
University of Washington Medical Center
Seattle, WA

Mark J. Russo, MD
RWJBarnabas
Newark, NJ

Agenda

12:30 pm AS Is Deadly! Does "Watchful Waiting" Make Sense In 2017?
Philippe Généreux
12:40 pm Focused Discussion
12:42 pm Stroke Following TAVR: Evolution From ‘Achilles Heel’ to Clinical Benefit (Compared to SAVR)
Susheel Kodali
12:52 pm Focused Discussion
12:54 pm Surgical Outcomes In Non-TAVR Centers: Should We Be Concerned?
James M. McCabe
1:04 pm Focused Discussion
1:06 pm The Case Volume vs Outcomes Relationship From the TVT Registry Using SAPIEN 3: Fact Or Fantasy?
Mark J. Russo
1:16 pm Focused Discussion
1:18 pm Is TAVR the Gold Standard for AS in 2017?
 
1:18 pm An Interventionalist’s Perspective
Martin B. Leon
 
1:23 pm A Surgeon’s Perspective
Vinod H. Thourani
1:28 pm Focused Discussion
1:30 pm Adjourn

Trialign: The Next Era in Tricuspid Repair

Sponsored by Mitralign
Room: Chicago Ballroom VIII

Chairs

Scott Lim, MD
UVA Medical Center
Charlottesville, VA

Joachim Schofer, MD
Hamburg University Cardiovascular Center
Department of Structural Heart Disease
Hamburg, Germany

Faculty

Azeem Latib, MB
EMO-GVM Centro Cuore Columbus
Milan, Italy

Christopher U. Meduri, MD, MPH
Piedmont Heart Institute
Atlanta, GA

Rebecca Hahn, MD
NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, New York

Charles Davidson, MD
Northwestern Memorial Hospital
Chicago, IL

Agenda

12:30 PM Trialign: Device Overview and Taped Case
Azeem Latib
12:45 PM SCOUT I Update
Rebecca Hahn
1:00 PM Trialign SCOUT I Case Examples
Charles Davidson
1:15 PM How to Build a Tricuspid Program
Christopher Meduri
1:30 PM Adjourn

Afternoon Program

4:30 pm-5:00 pm – Check-in & Reception
5:00 pm-6:00 pm – Program


The Lotus Valve: REPRISE III Data and Beyond (Non-CME)

Sponsored by Boston Scientific
Room: Chicago Ballroom VIII

Chairs

Ted Feldman, MD
Evanston Hospital
Evanston, IL

Prof. Thomas Walther, MD
Kerckhoff Klinik Bad Nauheim
Bad Nauheim, Germany

Faculty

Prof. Anna Sonia Petronio, MD
S. D. Laboratorio di Emodinamica
Pisa, Italy

Vivek Rajagopal, MD
Piedmont Heart Institue
Atlanta, GA

Michael J. Reardon, MD
Houston Methodist Hospital
Houston, TX

Agenda

5:00 pm The REPRISE III Pivotal IDE Trial With the Lotus Valve: An Investigator’s Insight
Ted Feldman
5:12 pm Discussion
5:18 pm REPRISE III Secondary End Points in Perspective
Vivek Rajagopal
5:30 pm Discussion
5:36 pm The Path Ahead for the Lotus Valve
Anna Sonia Petronio
5:48 pm Discussion
5:54 pm Final Discussion Topic: Treating a Wider Patient Population With Aortic Stenosis - The Complementary Strategy of the Lotus and ACURATE Valves
6:00 pm Adjourn

Friday, June 16, 2017

Breakfast Programs

6:30 am-7:00 am – Check-in & Breakfast
7:00 am-8:00 am – Program
Breakfast will be served.


Beyond the Basics: Balloon Aortic Valvuloplasty in the TAVR Era (Non-CME)

Sponsored by the Cardiovascular Research Foundation
Supported through an educational grant from Bard Peripheral Vascular

Room: Chicago Ballroom X

Chair

Brij Maini, MD
Tenet Florida
Delray, FL

Faculty

Brian T. Bethea, MD
Tenet Atlantic Coastal Region
Delray Beach, FL

Cheng-Han Chen, MD, PhD
NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

John K. Forrest, MD
Yale New Haven Hospital
New Haven, CT

Azeem Latib, MB, BCh
EMO-GVM Centro Cuore Columbus
Milan, Italy

Saurabh Sanon, MD
Palm Beach Gardens Medical Center- Tenet Health
Palm Beach Gardens, FL

Agenda

7:00 am Role of Balloon Aortic Valvuloplasty in the Era of TAVR
Saurabh Sanon
 
7:10 am Predilatation During TAVR: When Is It Mandatory?
Brian T. Bethea
 
7:20 am Optimizing Post-Dilatation With Self-Expanding Valves: Does Balloon Choice (Size, Type) Matter?
John K. Forrest
 
7:30 am New Aortic Valvuloplasty Devices: The BARD TRUE and TRUE-FLOW Balloons
(Understanding the Technology)

Azeem Latib
 
7:40 am The BARD TRUE FLOW Experience: Clinical Examples and Results
Cheng-Han Chen
 
7:50 am Discussion  
8:00 am Adjourn  

What You Need to Know About Cerebral Embolic Protection (CEP) (Non-CME)

Sponsored by Keystone Heart
Room: Chicago Ballroom VIII

Chair

Martin B. Leon, MD
NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Faculty

Hemal Gada, MD, MBA
PinnacleHealth CardioVascular Institute
Harrisburg, PA

Alexandra J. Lansky, MD
Yale School of Medicine
New Haven, CT

Jeffrey W. Moses, MD
NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Rahul Sharma, MD
Cedars-Sinai Medical Center
Los Angeles, CA

7:00 am The Need for CEP
Martin B. Leon
 
7:12 am NeuroARC: New Stroke Guidelines for Diagnosis and Reporting
Alexandra J. Lansky
 
7:24 am Meaningful End Points of CEP Clinical Trials to Support Adoption: Major Stroke, Minor Stroke, Imaging?
Rahul Sharma
 
7:36 am An Update on Clinical Evidence to Support CEP During TAVR
Jeffrey W. Moses
 
7:48 am The Economic Impact of CEP During Cardiovascular Procedures
Hemal Gada
 
8:00 am Adjourn


Lunch Programs

12:15 pm-12:30 pm – Check-in & Lunch
12:30 pm-1:30 pm – Program
Lunch will be served.

TAVR Evolves: Are You and the Heart Team Ready? (CME)

Sponsored by the Cardiovascular Research Foundation
Supported through an educational grant from Medtronic

Room: Chicago Ballroom X

Chair

A. Pieter Kappetein, MD, PhD
Erasmus MC
Rotterdam, The Netherlands

Faculty

Brij Maini, MD
Tenet Health
Delray, FL

Christopher U. Meduri, MD
Piedmont Heart Institute
Atlanta, GA

Michael J. Reardon, MD
Houston Methodist Hospital
Houston, TX

Nicolas M. Van Mieghem, MD
Erasmus MC
Rotterdam, The Netherlands

Agenda

12:30 pm Going Beyond the Intermediate-Risk Patient: The New Boundaries for Transcatheter Therapy
Michael J. Reardon
12:42 pm How Many Patients Would Qualify for TAVI if All Intermediate-Risk Patients Would Be Treated With TAVR?
Christopher U. Meduri
12:54 pm How to Meet the Logistical Challenges of a Rapidly Growing Program
Nicolas M. Van Mieghem
1:06 pm Leveraging the TAVR Experience Into TMVR: Similarities and Differences for the Heart Team
Brij Maini
1:18 pm Panel Q&A
1:30 pm Adjourn

MitraClip: An Interactive Program
Optimizing Outcomes: A Case-Based Program (CME)

Sponsored by the Cardiovascular Research Foundation
Supported through an educational grant from Abbott 

Room: Chicago Ballroom VIII

Chair

Mark Reisman, MD
University of Washington Medical Center
Seattle, WA

Faculty/Panel

Ralph Stephan von Bardeleben, MD
University Medical Center Mainz
Mainz, Germany

Saibal Kar, MD
Cedars-Sinai Medical Center
Los Angeles, CA

Karl-Heinz Kuck, MD
Asklepios Klinik St. Georg
Hamburg, Germany

Azeem Latib, MB, BCh
EMO-GVM Centro Cuore Columbus
Milan, Italy

G. Burkhard Mackensen, MD, PhD
University of Washington
Seattle, WA

Francesco Maisano, MD
UniversitätsSpital Zürich
Zürich, Switzerland

Agenda

12:30 pm Welcome and Introductions
Mark Reisman
  TOPIC I: How Many and Where to Position the MitraClip
12:31 pm Functional MR: Case Presentation
Ralph Stephan von Bardeleben
12:41 pm Degenerative MR: Case Presentation
Saibal Kar
  TOPIC II: How to Effectively Gauge Success
12:51 pm Case Presentation : Using LA Pressure as a Guide to MitraClip Therapy
Franceso Maisano
1:01 pm Case Presentation: Balancing Residual MR and Inflow Gradient
Karl-Heinz Kuck
  TOPIC III: Management of “Late” Single Leaflet Detachment
1:11 pm Case Presentation
G. Burkhard Mackensen
  TOPIC IV: The MitraClip for Tricuspid Regurgitation
1:21 pm Case Presentation
Azeem Latib
1:30 pm Adjourn

The Next Revolution: Transcatheter Mitral and Tricuspid Therapies Are Coming! (CME) 

Sponsored by Cardiovascular Research Foundation
Supported through an educational grant from Edwards Lifesciences 

Room: Sheraton Ballroom II

Chairs

Michael J. Mack, MD
Baylor – Plano Heart Hospital
Dallas, TX

Mark Reisman, MD
University of Washington Medical Center
Seattle, WA

Faculty

James S. Gammie, MD
University of Maryland School of Medicine
Baltimore, MD

Jeffrey J. Popma, MD
Beth Israel Deaconess Hospital
Boston, MA

John G. Webb, MD
St. Paul’s Hospital
Vancouver, British Columbia, CA

Vinod H. Thourani, MD
Emory University Hospital Midtown
Atlanta, GA

Agenda

12:30 pm How to Develop a Successful Mitral/Tricuspid Heart Team and Valve Clinic: Anecdotes, Tips, and Case Studies
Mark Reisman
12:40 pm Focused Discussion
12:42 pm Transcatheter TR Therapy: Lessons From the Operating Room
James S. Gammie
12:52 pm Focused Discussion
12:54 pm Differences Between TMVR and TAVR: Imaging, Patients, and Clinical Trial Strategies
Jeffrey J. Popma
1:04 pm Focused Discussion
1:06 pm The Components of a “Toolbox” Approach to Transcatheter Mitral Valve Therapies
Vinod H. Thourani
1:16 pm Focused Discussion
1:18 pm Innovative Transcatheter Therapies for Managing Patients With Severe TR
John G. Webb
1:28 pm Focused Discussion
1:30 pm Adjourn